50-112-2416

MERTK Monoclonal Antibody (HMER5DS), PE, eBioscience™, Invitrogen™

Manufacturer: Invitrogen

Select a Size

Pack Size SKU Availability Price
Each 50-112-2416-Each In Stock ₹ 32,186.85

50-112-2416 - Each

₹ 32,186.85

In Stock

Quantity

1

Base Price: ₹ 32,186.85

GST (18%): ₹ 5,793.633

Total Price: ₹ 37,980.483

Antigen

MERTK

Classification

Monoclonal

Concentration

5 μL/Test

Formulation

PBS with 0.2% BSA and 0.09% sodium azide; pH 7.2

Gene Accession No.

Q12866

Gene Symbols

Mertk

Immunogen

hMer-FC, PFA 1/2 + 1/2

Quantity

100 Tests

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG1 κ

Applications

Flow Cytometry

Clone

HMER5DS

Conjugate

PE

Gene

Mertk

Gene Alias

c-Eyk; c-mer; c-mer proto-oncogene tyrosine kinase; Eyk; MER; MER proto-oncogene, tyrosine kinase; MER receptor tyrosine kinase; MERTK; MGC133349; nmf12; Nyk; Proto-oncogene c-Mer; proto-oncogene tyrosine-protein kinase MER; rdy; receptor tyrosine kinase MerTK; Receptor tyrosine tinase gene probably the gene for Rdy; retinal dystrophy; RP38; sMER; sMERTK; soluble MER; soluble MERTK; STK kinase; Tyro 12; Tyro12; Tyrosine-protein kinase Mer

Host Species

Mouse

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

10461

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Form

Liquid

Related Products

Img

Invitrogen

36-857-5182

--

Img

Invitrogen

47-117-842

--

Img

Invitrogen

50-112-2091

--

Img

Invitrogen

50-112-3936

--

Img

Invitrogen

50-112-24

--

Img

Invitrogen

44-912

--

Img

Invitrogen

46-117-282

--

Img

Invitrogen

37-320-0

--

Description

  • Description: This HMER5DS antibody recognizes human MerTK, known also as Mer or c-mer, a 170-210 kDa member of the TAM family of tyrosine kinase receptors that also includes Axl and Tyro3
  • MerTK is expressed on a subset of anti-inflammatory macrophages and is involved in the removal of apoptotic cells
  • This process relies on two soluble ligands of Mer,TK Protein S and Gas6, that coat the surface of cells undergoing apoptosis
  • Upon binding these ligands, MerTK undergoes autophosphorylation at multiple tyrosine residues that activate the PI3K and Akt pathways
  • This results in the phagocytosis of target cells and also the direct inhibition of TLR-induced production of pro-inflammatory cytokines by the phagocytes
  • Mer may also function as a putative entry receptor for filoviruses
  • Deficiency of MerTK causes general autoimmunity, inflammation, and accumulation of apoptotic bodies
  • MerTK can be released from the cell surface by metalloproteinases, and this process is significantly enhanced when macrophages are stimulated, e.g
  • with LPS
  • MerTK is often expressed on maligt cells, and may be implicated in immune evasion
  • Applications Reported: This HMER5DS antibody has been reported for use in flow cytometric analysis
  • Applications Tested: This HMER5DS antibody has been pre-titrated and tested by flow cytometric analysis of human monocyte-derived macrophages
  • This can be used at 5 μL (0.06 μg) per test
  • MERTK (cMER) is a tyrosine kinase proto-oncogene and is involved in the retinal pigment epithelium (RPE) phagocytosis pathway, which is implicated in human retinal disease
  • Regulates many physiological processes including cell survival, migration, differentiation, and phagocytosis of apoptotic cells (efferocytosis)
  • Ligand binding at the cell surface induces autophosphorylation of MERTK on its intracellular domain that provides docking sites for downstream signaling molecules
  • Following activation by ligand, interacts with GRB2 or PLCG2 and induces phosphorylation of MAPK1, MAPK2, FAK/PTK2 or RAC1
  • MERTK signaling plays a role in various processes such as macrophage clearance of apoptotic cells, platelet aggregation, cytoskeleton reorganization and engulfment
  • Functions in the retinal pigment epithelium (RPE) as a regulator of rod outer segments fragments phagocytosis
  • Plays also an important role in inhibition of Toll-like receptors (TLRs)-mediated innate immune response by activating STAT1, which selectively induces production of suppressors of cytokine signaling SOCS1 and SOCS3.